• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用液相色谱-串联质谱法测定大鼠血浆和脑组织中的亲脂性抗精神病药物齐拉西酮。

Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry.

作者信息

Zhang Guodong, Terry Alvin V, Bartlett Michael G

机构信息

Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, The University of Georgia, Athens, GA 30602-2352, USA.

出版信息

Biomed Chromatogr. 2008 Jul;22(7):770-8. doi: 10.1002/bmc.999.

DOI:10.1002/bmc.999
PMID:18318016
Abstract

A simple, sensitive and robust liquid chromatography/electrospray ionization tandem mass spectrometry (LCESI-MS/MS) method with low matrix effects was developed and validated for the quantification of the lipophilic antipsychotic ziprasidone from rat plasma and brain tissue. Ziprasidone was extracted from rat plasma and brain homogenate using a single-step liquid-liquid extraction. Ziprasidone was separated on an Agilent Eclipse XDB C8 column (150 x 2.1 mm i.d., 5 microm) column using a mobile phase of acetonitrile-0.02% ammonia in water (pH 7.20 adjusted with formic acid) using gradient elution. Ziprasidone was detected in the positive ion mode using multiple reaction monitoring. The method was validated and the specificity, linearity, lower limit of quantitation (LLOQ), precision, accuracy, recovery, matrix effects and stability were determined. The LLOQ was 0.2 ng/mL for plasma and 0.833 ng/g for brain tissue. The method was linear over the concentration range from 0.2 to 200.0 ng/mL for plasma and 0.833-833.3 ng/g for brain tissue. The correlation coefficient (R2) values were more than 0.996 for both plasma and brain homogenate. The precision and accuracy intra-day and inter-day were better than 8.13%. The relative and absolute recovery was above 81.0% and matrix effects were lower than 5.2%. This validated method has been successfully used to quantify the rat plasma and brain tissue concentration of ziprasidone after chronic treatment.

摘要

建立了一种简单、灵敏且稳健的液相色谱/电喷雾电离串联质谱法(LC-ESI-MS/MS),该方法具有较低的基质效应,用于定量大鼠血浆和脑组织中的亲脂性抗精神病药物齐拉西酮。采用单步液液萃取法从大鼠血浆和脑匀浆中提取齐拉西酮。使用乙腈-0.02%氨水溶液(用甲酸调节pH至7.20)作为流动相,采用梯度洗脱,在安捷伦Eclipse XDB C8柱(150×2.1 mm内径,5μm)上分离齐拉西酮。采用多反应监测在正离子模式下检测齐拉西酮。对该方法进行了验证,并测定了特异性、线性、定量下限(LLOQ)、精密度、准确度、回收率、基质效应和稳定性。血浆的LLOQ为0.2 ng/mL,脑组织的LLOQ为0.833 ng/g。该方法在血浆浓度范围为0.2至200.0 ng/mL、脑组织浓度范围为0.833至833.3 ng/g时呈线性。血浆和脑匀浆的相关系数(R2)值均大于0.996。日内和日间精密度和准确度均优于8.13%。相对回收率和绝对回收率均高于81.0%,基质效应低于5.2%。该经过验证的方法已成功用于定量慢性治疗后大鼠血浆和脑组织中齐拉西酮的浓度。

相似文献

1
Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry.使用液相色谱-串联质谱法测定大鼠血浆和脑组织中的亲脂性抗精神病药物齐拉西酮。
Biomed Chromatogr. 2008 Jul;22(7):770-8. doi: 10.1002/bmc.999.
2
Sensitive liquid chromatography/tandem mass spectrometry method for the determination of the lipophilic antipsychotic drug chlorpromazine in rat plasma and brain tissue.用于测定大鼠血浆和脑组织中亲脂性抗精神病药物氯丙嗪的灵敏液相色谱/串联质谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jul 1;854(1-2):68-76. doi: 10.1016/j.jchromb.2007.03.045. Epub 2007 Apr 8.
3
Liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat plasma.液相色谱/串联质谱法同时测定大鼠血浆中的奥氮平、利培酮、9-羟基利培酮、氯氮平、氟哌啶醇和齐拉西酮
Rapid Commun Mass Spectrom. 2007;21(6):920-8. doi: 10.1002/rcm.2914.
4
Determination of aripiprazole in rat plasma and brain using ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry.采用超高效液相色谱/电喷雾电离串联质谱法测定大鼠血浆和脑中的阿立哌唑。
Biomed Chromatogr. 2012 Nov;26(11):1325-32. doi: 10.1002/bmc.2698. Epub 2012 Jan 18.
5
Quantitative determination of zidovudine diaryl phosphate triester pro-drugs in rat plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.高效液相色谱-电喷雾电离串联质谱法对大鼠血浆中齐多夫定二芳基磷酸三酯前体药物的定量测定
J Pharm Biomed Anal. 2008 Dec 15;48(5):1417-24. doi: 10.1016/j.jpba.2008.11.023. Epub 2008 Nov 27.
6
Determination of ziprasidone in human plasma by liquid chromatography-electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients.
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 1;847(2):237-44. doi: 10.1016/j.jchromb.2006.10.024. Epub 2006 Nov 13.
7
Determination of chlorpyrifos and its metabolites in rat brain tissue using coupled-column liquid chromatography/electrospray ionization tandem mass spectrometry.使用联用柱液相色谱/电喷雾电离串联质谱法测定大鼠脑组织中的毒死蜱及其代谢物。
Rapid Commun Mass Spectrom. 2006;20(18):2689-95. doi: 10.1002/rcm.2647.
8
Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high-performance liquid chromatography with tandem mass spectrometry.采用高效液相色谱-串联质谱法对大鼠血浆中一种非典型抗精神病药物鲁拉西酮进行定量分析。
Biomed Chromatogr. 2011 Dec;25(12):1389-94. doi: 10.1002/bmc.1625. Epub 2011 Mar 9.
9
Development and validation of a LC-MS/MS method with electrospray ionization for determination of LASSBio-579 in rat plasma.一种用于测定大鼠血浆中LASSBio-579的电喷雾电离液相色谱-串联质谱法的开发与验证
J Pharm Biomed Anal. 2007 Jan 17;43(2):677-82. doi: 10.1016/j.jpba.2006.07.052. Epub 2006 Sep 18.
10
Determination of 5-HT receptor antagonists, MEFWAY and MPPF using liquid chromatography electrospray ionization tandem mass spectrometry in rat plasma and brain tissue.采用液相色谱-电喷雾串联质谱法测定大鼠血浆和脑组织中的 5-HT 受体拮抗剂 MEFWAY 和 MPPF
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jan 15;913-914:24-9. doi: 10.1016/j.jchromb.2012.11.014. Epub 2012 Nov 27.

引用本文的文献

1
Development of a simultaneous LC-MS/MS analytical method for plasma: 16 antipsychotics approved in Japan and 4 drug metabolites.建立一种同时测定血浆中 16 种日本批准的抗精神病药物及其 4 种代谢物的 LC-MS/MS 分析方法。
Anal Sci. 2024 Sep;40(9):1749-1763. doi: 10.1007/s44211-024-00619-2. Epub 2024 Jun 25.
2
Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS.基于与 A 腺苷和 AChE 受体的对接、脑 GLP-1 反应以及大鼠 28 天多次给药后 LC-MS/MS 测定的脑/血浆浓度比,奥马利格列汀的神经保护作用再利用。
Molecules. 2021 Feb 8;26(4):889. doi: 10.3390/molecules26040889.
3
Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.
将 Omarigliptin 重新定位为每周一次的鼻内抗帕金森病药物。
Sci Rep. 2018 Jun 12;8(1):8959. doi: 10.1038/s41598-018-27395-0.
4
Stability-indicating spectrofluorimetric method for the assay of ziprasidone in capsules.用于胶囊中齐拉西酮测定的稳定性指示光谱荧光光度法。
J Fluoresc. 2011 Jul;21(4):1659-67. doi: 10.1007/s10895-011-0855-x. Epub 2011 Feb 16.